Acutaas Chemicals Limited (NSEI: ACUTAAS)
Health Care · Pharmaceuticals · IN
Rs3,169.00
-2.06% today · +121.7% 1Y
Acutaas Chemicals Limited (NSEI: ACUTAAS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.71B and employs 879 people.
Over the last twelve months the share price has gained 121.7%, trading between 1.30K and 3.74K.
Tweenvest scores Acutaas Chemicals Limited across four factors: quality 78/100, value 25/100, growth 100/100, dividend 40/100. Its strongest factor is growth.
ACUTAAS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.71B
- Revenue (TTM)
- $154.60M
- P/E
- 67.46
- EPS
- 46.98
- Dividend yield
- 0.08%
- Beta (5Y)
- 0.03
- 52-week high
- Rs3,740.00
- 52-week low
- Rs1,302.00
- Avg volume (3M)
- —
- Shares outstanding
- 81.87M
- Employees
- 879
- Next earnings
- —
About Acutaas Chemicals Limited
Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.
- ISIN
- INE00FF01025
- Founded
- 2004
- Listed since
- Sep 14, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.